查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1772200

美国横向流动化验市场规模、份额、趋势分析报告：按产品、应用、技术、最终用途、细分市场预测，2025-2033

U.S. Lateral Flow Assay Market Size, Share & Trends Analysis Report By Product, By Application, By Technique, By End use, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

美国横向流动化验市场趋势：

预计 2024 年美国横向流动化验市场规模将达到 28.2 亿美元，到 2033 年将达到 46.3 亿美元，2025 年至 2033 年的复合年增长率为 6.08%。

不断上升的感染疾病疫情给全球公共卫生系统带来巨大压力。随着都市化加快、互联互通程度加深、抗生素抗药性加剧以及气候变迁的影响日益加剧，专家们强调加强感染疾病监测、预防和诊断能力的迫切需求。全球感染疾病的增加是横向流动检测 (LFA) 市场的主要驱动力，该市场需要快速诊断解决方案。根据美国美国病例数将从 2022 年的 7,874 例增加到 2024 年的 10,347 例，这反映出一项显着的公共卫生挑战。

由于西尼罗河病毒 (WNV)、登革热、基孔肯雅病、兹卡病毒、疟疾和黄热病等蚊媒性行为感染的盛行率不断上升，预计蚊媒疾病检测产业将显着成长。这些感染疾病的增加对快速有效的诊断解决方案的需求很高，尤其是在疫情易发地区。据美国疾病管制与预防中心 (CDC) 称，西尼罗河病毒 (WNV) 在美国流行，美国所有 48 个州和哥伦比亚特区均有报告病例，主要发生在夏季和秋季。截至 2024 年 11 月，CDC 已记录 1,466 例 WNV 感染病例，2022 年报告了 913 例人类病例，其中 70% 为神经侵入性，30% 为非神经侵入性。蚊媒疾病负担的增加，加上 COVID-19 和猴痘等持续存在的健康危机，凸显了有效诊断和监测措施的迫切性。

公共卫生工作在扩大市场方面也发挥关键作用。美国疾病管制与预防中心（CDC）的国际流感计画专注于流感监测、大流行防范、调查和疫苗接种计画。此外，全国县市卫生负责人协会协助地方卫生部门进行流感预防和应变工作。

目录

第一章调查方法与范围

第二章执行摘要

第三章美国横向流动化验市场变数、趋势与范围

  • 市场介绍/电网展望
  • 市场规模和成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 市场机会分析
    • 市场问题分析
  • 美国横向流动化验市场分析工具
    • 波特分析
    • PESTEL分析

第四章美国横向流动化验市场：产品预估与趋势分析

  • 美国横向流动化验市场：产品变异分析
  • 按产品 2024 年及 2033 年
  • 套件和试剂
  • 侧向流读取仪
    • 桌上型读数仪
    • 数字领袖

第五章美国横向流动化验市场：应用评估与趋势分析

  • 美国横向流动化验市场：应用趋势分析
  • 按应用 2024 年和 2033 年
  • 临床试验
    • 传染病检查
    • 心臟标记检测
    • 妊娠和生育能力测试
    • 胆固醇检测/血脂分析
    • 药物滥用检测
    • 其他实验室检查
  • 兽医诊断
  • 食品安全与环境检测
  • 药物开发和品质测试

第六章美国横向流动化验市场：技术评估与趋势分析

  • 美国横向流动化验市场：技术变革分析
  • 2024年和2033年的技术
  • 夹心试验
  • 竞争分析
  • 多重检测分析

第七章美国横向流动化验市场：最终用途估计与趋势分析

  • 美国横向流动化验市场：最终用途变异分析
  • 按最终用途划分，2024 年和 2033 年
  • 医院和诊所
  • 诊断实验室
  • 居家护理
  • 製药和生物技术公司
  • 其他用途

第八章 竞争态势

  • 主要市场参与企业的近期趋势和影响分析
  • 公司分类
  • 公司热图分析
  • 公司简介
    • Abbott
    • Bio-Rad Laboratories, Inc
    • Siemens Healthineers AG
    • BIOMERIEUX
    • BD
    • QIAGEN
    • QuidelOrtho Corporation
    • F. Hoffmann-La Roche
    • DH Life Sciences, LLC.
    • Quest Diagnostics
Product Code: GVR-4-68040-646-5

U.S. Lateral Flow Assay Market Trends:

The U.S. lateral flow assay market size was valued at USD 2.82 billion in 2024 and is projected to reach USD 4.63 billion by 2033, growing at a CAGR of 6.08% from 2025 to 2033. The rising prevalence of infectious diseases places immense pressure on public health systems worldwide. With increasing urbanization, interconnectivity, antimicrobial resistance, and the rising impact of climate change, experts stress the urgent need for enhanced infectious disease surveillance, prevention, and diagnostic capabilities. The global rise in infectious diseases significantly drives the lateral flow assays (LFA) market by necessitating rapid diagnostic solutions. According to the Centers for Disease Control and Prevention (CDC), tuberculosis (TB) cases in the U.S. increased from 7,874 in 2022 to 10,347 in 2024, reflecting a notable public health challenge.

The mosquito-borne disease testing segment is projected to experience significant growth due to the rising prevalence of mosquito-borne infections, including West Nile virus (WNV), dengue, chikungunya, Zika virus, malaria, and yellow fever. The increasing incidence of these diseases has heightened the demand for rapid and efficient diagnostic solutions, particularly in regions prone to outbreaks. According to the Centers for Disease Control and Prevention (CDC), West Nile virus (WNV) has become endemic in the U.S., with cases reported in all 48 contiguous states and the District of Columbia, predominantly during the summer and fall months. As of November 2024, the CDC recorded 1,466 cases of WNV, while in 2022, 913 human cases were reported, with 70% classified as neuroinvasive and 30% as non-neuroinvasive. The increasing burden of mosquito-borne diseases, alongside ongoing health crises such as COVID-19 and monkeypox, underscores the urgent need for effective diagnostic and surveillance measures.

Public health initiatives also play a crucial role in market expansion. The CDC's Influenza Division International Program focuses on surveillance, pandemic preparedness, research, and vaccination programs to combat influenza. Additionally, the National Association of County and City Health Officials supports local health departments in influenza prevention and control.

U.S. Lateral Flow Assay Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. lateral flow assay market report based on product, application, technique, and end use:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Kits & Reagents
  • Lateral Flow Readers
  • Benchtop Readers
  • Digital Readers
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Clinical Testing
    • Infectious Disease Testing
    • COVID-19
    • Mosquito Borne Disease Testing
    • Malaria Testing
    • Dengue Testing
    • Zika Testing
    • Chikungunya Testing
    • Others
    • Influenza Testing
    • Sexually Transmitted Infection Testing
    • HIV Testing
    • HPV Testing
    • Chlamydia Testing
    • Gonorrhea Testing
    • Syphilis Testing
    • Other STI Testing
    • Hepatitis
    • Tuberculosis
    • Other Infectious Diseases
    • Cardiac Marker Testing
    • Troponin I and T Testing
    • CK-MB Testing
    • BNP and NT-Probnp Testing
    • Myoglobin Testing
    • D-Dimer Testing
    • Other Cardiac Marker Tests
    • Pregnancy & Fertility Testing
    • Pregnancy Testing
    • Fertility Testing
    • Cholesterol Testing/Lipid Profile
    • Drugs of Abuse Testing
    • Other Clinical Tests
  • Veterinary Diagnostics
  • Food Safety & Environment Testing
  • Drug Development & Quality Testing
  • Technique Outlook (Revenue, USD Million, 2021 - 2033)
  • Sandwich Assays
  • Competitive Assays
  • Multiplex Detection Assays
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Home Care
  • Pharmaceutical & Biotechnology Companies
  • Others

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Lateral Flow Assay Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
      • 3.3.1.1. Increasing prevalence of infectious diseases
      • 3.3.1.2. Technological advancements in lateral flow
      • 3.3.1.3. Growing adoption in homecare settings
    • 3.3.2. Market Restraints Analysis
      • 3.3.2.1. Stringent Regulations
    • 3.3.3. Market Opportunities Analysis
      • 3.3.3.1. Growing demand for Point-of-Care (POC) Testing
      • 3.3.3.2. Expanding applications beyond healthcare
    • 3.3.4. Market Challenges Analysis
      • 3.3.4.1. Product Recalls
  • 3.4. U.S. Lateral Flow Assay Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. U.S. Lateral Flow Assay Market: Product Estimates & Trend Analysis

  • 4.1. U.S. Lateral Flow Assay Market: Product Movement Analysis
  • 4.2. U.S. Lateral Flow Assay Market Estimates and Forecasts, by Product 2024 & 2033 (USD Million)
  • 4.3. Kits & Reagents
    • 4.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4. Lateral Flow Readers
    • 4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.2. Benchtop Readers
      • 4.4.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. Digital Readers
      • 4.4.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Lateral Flow Assay Market: Application Estimates & Trend Analysis

  • 5.1. U.S. Lateral Flow Assay Market: Application Movement Analysis
  • 5.2. U.S. Lateral Flow Assay Market Estimates and Forecasts, by Application 2024 & 2033 (USD Million)
  • 5.3. Clinical Testing
    • 5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.3.2. Infectious Disease Testing
      • 5.3.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.3.2.2. COVID-19
        • 5.3.2.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.3.2.3. Mosquito Borne Disease Testing
        • 5.3.2.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
        • 5.3.2.3.2. Malaria Testing
          • 5.3.2.3.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
        • 5.3.2.3.3. Dengue Testing
          • 5.3.2.3.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
        • 5.3.2.3.4. Zika Testing
          • 5.3.2.3.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
        • 5.3.2.3.5. Chikungunya Testing
          • 5.3.2.3.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
        • 5.3.2.3.6. Others
          • 5.3.2.3.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.3.2.4. Influenza Testing
        • 5.3.2.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.3.2.5. Sexually Transmitted Infection Testing
        • 5.3.2.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
        • 5.3.2.5.2. HIV Testing
          • 5.3.2.5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
        • 5.3.2.5.3. HPV Testing
          • 5.3.2.5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
        • 5.3.2.5.4. Chlamydia Testing
          • 5.3.2.5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
        • 5.3.2.5.5. Gonorrhea Testing
          • 5.3.2.5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
        • 5.3.2.5.6. Syphilis Testing
          • 5.3.2.5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
        • 5.3.2.5.7. Other STI Testing
          • 5.3.2.5.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.3.2.6. Hepatitis
        • 5.3.2.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.3.2.7. Tuberculosis
        • 5.3.2.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.3.2.8. Other Infectious Diseases
        • 5.3.2.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.3.3. Cardiac Marker Testing
      • 5.3.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.3.3.2. Troponin I and T Testing
        • 5.3.3.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.3.3.3. CK-MB Testing
        • 5.3.3.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.3.3.4. BNP and NT-Probnp Testing
        • 5.3.3.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.3.3.5. Myoglobin Testing
        • 5.3.3.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.3.3.6. D-Dimer Testing
        • 5.3.3.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.3.3.7. Other Cardiac Marker Tests
        • 5.3.3.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.3.4. Pregnancy & Fertility Testing
      • 5.3.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.3.4.2. Pregnancy Testing
        • 5.3.4.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.3.4.3. Fertility Testing
        • 5.3.4.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.3.5. Cholesterol Testing/Lipid Profile
      • 5.3.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.3.6. Drugs of Abuse Testing
      • 5.3.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.3.7. Other Clinical Tests
      • 5.3.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4. Veterinary Diagnostics
    • 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Food Safety & Environment Testing
    • 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Drug Development & Quality Testing
    • 5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Lateral Flow Assay Market: Technique Estimates & Trend Analysis

  • 6.1. U.S. Lateral Flow Assay Market: Technique Movement Analysis
  • 6.2. U.S. Lateral Flow Assay Market Estimates and Forecasts, by Technique 2024 & 2033 (USD Million)
  • 6.3. Sandwich Assays
    • 6.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. Competitive Assays
    • 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Multiplex Detection Assays
    • 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. U.S. Lateral Flow Assay Market: End Use Estimates & Trend Analysis

  • 7.1. U.S. Lateral Flow Assay Market: End-use Movement Analysis
  • 7.2. U.S. Lateral Flow Assay Market Estimates and Forecasts, by End-use 2024 & 2033 (USD Million)
  • 7.3. Hospitals & Clinics
    • 7.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4. Diagnostic Laboratories
    • 7.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Home Care
    • 7.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Pharmaceutical & Biotechnology Companies
    • 7.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Other End-use
    • 7.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Heat Map Analysis
  • 8.4. Company Profiles
    • 8.4.1. Abbott
      • 8.4.1.1. Participant's Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Recent Developments/ Strategic Initiatives
    • 8.4.2. Bio-Rad Laboratories, Inc
      • 8.4.2.1. Participant's Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Recent Developments/ Strategic Initiatives
    • 8.4.3. Siemens Healthineers AG
      • 8.4.3.1. Participant's Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Recent Developments/ Strategic Initiatives
    • 8.4.4. BIOMERIEUX
      • 8.4.4.1. Participant's Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Recent Developments/ Strategic Initiatives
    • 8.4.5. BD
      • 8.4.5.1. Participant's Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Recent Developments/ Strategic Initiatives
    • 8.4.6. QIAGEN
      • 8.4.6.1. Participant's Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Recent Developments/ Strategic Initiatives
    • 8.4.7. QuidelOrtho Corporation
      • 8.4.7.1. Participant's Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Recent Developments/ Strategic Initiatives
    • 8.4.8. F. Hoffmann-La Roche
      • 8.4.8.1. Participant's Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Recent Developments/ Strategic Initiatives
    • 8.4.9. DH Life Sciences, LLC.
      • 8.4.9.1. Participant's Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Recent Developments/ Strategic Initiatives
    • 8.4.10. Quest Diagnostics
      • 8.4.10.1. Participant's Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Recent Developments/ Strategic Initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 U.S. lateral flow assay market, by region, 2018 - 2033 (USD Million)
  • Table 3 U.S. lateral flow assay market, by product, 2018 - 2033 (USD Million)
  • Table 4 U.S. lateral flow assay market, by technique, 2018 - 2033 (USD Million)
  • Table 5 U.S. lateral flow assay market, by application, 2018 - 2033 (USD Million)
  • Table 6 U.S. lateral flow assay market, by end-use, 2018 - 2033 (USD Million)

List of Figures

  • Fig. 1 U.S. lateral flow assay market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validating & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market outlook
  • Fig. 13 Segment snapshot-1
  • Fig. 14 Segment snapshot-2
  • Fig. 15 Competitive landscape snapshot
  • Fig. 16 Market trends & outlook
  • Fig. 17 Porter's five force analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 U.S. lateral flow assay market: Product outlook key takeaways
  • Fig. 20 U.S. lateral flow assay market: Product movement analysis
  • Fig. 21 Kits & reagents market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Lateral flow readers market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Benchtop readers market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Digital readers market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 U.S. lateral flow assay market: Application outlook key takeaways
  • Fig. 26 U.S. lateral flow assay market: Application movement analysis
  • Fig. 27 Clinical testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Infectious disease testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Covid-19 market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Mosquito borne disease testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Malaria Testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Dengue Testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Zika Testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Chikungunya Testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Influenza testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Sexually transmitted infection testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 HIV testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 HPV testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Chlamydia testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Gonorrhea testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Syphilis testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Other STI testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Hepatitis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Tuberculosis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Other infectious diseases market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Cardiac marker testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Troponin I and t testing
  • Fig. 49 CK-MB testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 BNP and NT-PROBNP testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Myoglobin testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 D-dimer testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Other cardiac marker tests market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Pregnancy & fertility testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Pregnancy testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Fertility testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Cholesterol testing/lipid profile market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Drugs of abuse testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Other clinical tests market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Veterinary diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Food safety & environment testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 Drug development & quality testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 U.S. lateral flow assay market: Technique outlook key takeaways
  • Fig. 64 U.S. lateral flow assay market: Technique movement analysis
  • Fig. 65 Sandwich assays market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 Competitive assays market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Multiplex detection assays market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 U.S. Lateral Flow Assay market: Test Type outlook key takeaways
  • Fig. 69 U.S. Lateral Flow Assay market: Test Type movement analysis
  • Fig. 70 Lateral flow immunoassay market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 Nucleic acid lateral flow assay market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 U.S. Lateral Flow Assay market: End-use outlook key takeaways
  • Fig. 73 U.S. Lateral Flow Assay market: End-use movement analysis
  • Fig. 74 Hospitals & clinics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 75 Diagnostic laboratories market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Home care market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 77 Pharmaceutical & biotechnology companies market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 Other End-use market estimates and forecasts, 2021 - 2033 (USD Million)